During the past decade, Urgent Care Clinical Trials conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Urgent Care Clinical Trials" are "Acute Respiratory Tract Infections" (1 trials) and "COVID-19 Respiratory Infection" (1 trials). Many other conditions were trialed in "Urgent Care Clinical Trials" in a lesser frequency.

Most popular intervention types in "Urgent Care Clinical Trials" are "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "FebriDx" (1 trials) and "The BinaxNOW™ Antibody Tests measure IgG antibodies against SARS-CoV-2." (1 trials). Other intervention names were less common.

The vast majority of trials in "Urgent Care Clinical Trials" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Urgent Care Clinical Trials". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Urgent Care Clinical Trials, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Urgent Care Clinical Trials, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".